...
首页> 外文期刊>Pathology International >Expression of p53 protein as a prognostic indicator of reduced survival time in diffuse-type gastric carcinoma.
【24h】

Expression of p53 protein as a prognostic indicator of reduced survival time in diffuse-type gastric carcinoma.

机译:p53蛋白的表达作为弥漫型胃癌生存时间减少的预后指标。

获取原文
获取原文并翻译 | 示例
           

摘要

To determine whether p53 expression is different in intestinal and diffuse types of gastric carcinoma, we investigated p53 immunohistochemical expression in 178 primary gastric carcinomas. Overexpression of p53 was observed in 50 out of 100 intestinal-type tumors (50.0%) and in 27 out of 78 diffuse-type tumors (34.6%). A significant difference was found in the timing of p53 overexpression between the two types of carcinomas. Overexpression of p53 occurred often in the early stage of intestinal-type tumors, and there was no significant difference in expression between early and advanced cancers. In contrast, p53 overexpression did not occur often in the early stage of diffuse-type tumors, but it increased progressively as the tumor advanced. Analysis of patient survival revealed that p53 overexpression correlates significantly with a poor prognosis in diffuse-type gastric carcinoma (P = 0.003) but not in intestinal-type. Multivariate analysis showed that only pathological stage was an independent prognostic indicator. Our results suggest that p53 overexpression plays a different role in tumor carcinogenesis and progression of these two types of gastric cancers.
机译:为了确定在肠道和弥漫型胃癌中p53表达是否不同,我们调查了178例原发性胃癌中p53免疫组织化学表达。在100种肠型肿瘤中有50种(50.0%)和78种弥散型肿瘤中有27种(34.6%)观察到p53过表达。在这两种类型的癌症之间,p53过表达的时间存在显着差异。 p53的过度表达通常发生在肠型肿瘤的早期,早期和晚期癌症之间的表达没有显着差异。相反,在弥漫型肿瘤的早期阶段,p53的过表达并不经常发生,但随着肿瘤的发展而逐渐增加。对患者生存率的分析表明,在弥漫型胃癌中,p53过表达与不良预后显着相关(P = 0.003),而在肠型中则不相关。多变量分析表明,只有病理阶段是独立的预后指标。我们的结果表明,p53过表达在这两类胃癌的肿瘤发生和发展中起着不同的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号